Sartorius is an internationally leading bioprocess and laboratory technology provider specializing in the design, manufacture, and service of integrated solutions covering fermentation, filtration, purification, fluid management and laboratory technologies. Re-usable and single-use bioreactors, microbial fermentors, filtration devices, integrity testers, housings, comprehensive single-use fluid handling, storage and mixing technologies, cell culture media, validation, training services & support are also provided across the company’s portfolio. "Turning science into solutions" is our primary focus.
E-mail: Maritza.ramirez@sartorius.com
Website: www.sartorius.us
Shows attending:
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.